ArticleThe Journal of clinical investigation2026

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.

Lisa Werr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.